The European Union has taken significant steps to update and strengthen the regulatory framework for medical devices and in vitro diagnostic medical devices. This revision was necessary to keep pace with rapid advancements in technology and medical science observed over the past two decades.
These changes signify a major overhaul intended to enhance patient safety, ensure product efficacy, and foster innovation within the EU’s healthcare sector. By aligning regulations with the latest developments in medical technology, the EU aims to maintain its stringent health and safety standards while also promoting a dynamic and competitive market environment.